Tobin Schilke
Direttore Finanziario/CFO presso REVANCE THERAPEUTICS, INC.
Patrimonio netto: 633 871 $ in data 30/04/2024
Posizioni attive di Tobin Schilke
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05/11/2018 | - |
| Direttore Finanziario/CFO | 05/11/2018 | - |
Storia della carriera di Tobin Schilke
Precedenti posizioni note di Tobin Schilke
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ACHAOGEN | Direttore Finanziario/CFO | 05/07/2016 | 01/10/2018 |
Roche Products Ltd.
 Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Direttore/Membro del Consiglio | 01/09/2012 | 01/06/2016 |
| Direttore Finanziario/CFO | 01/09/2012 | 01/06/2016 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/09/2012 | 01/08/2014 |
Formazione di Tobin Schilke
| Lafayette College | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Roche Products Ltd. manufactures diagnostic, diabetes, and pharmaceutical products. The company was founded on December 14, 1908 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Tobin Schilke
- Esperienza
